Synthesis and in vitro evaluation of a rhenium-cyclized somatostatin derivative series

Journal of Medicinal Chemistry

Volumn 51, Issue 5, 2008, Pages 1223-1230

  Bigott Hennkens, Heather M ^a   Junnotula, Sulochana ^a   Ma, Lixin ^a,b,c   Gallazzi, Fabio ^a   Lewis, Michael R ^a,b,c   Jurisson, Silvia S ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CYSTEINE DERIVATIVE; DISULFIDE; NITROGEN; OCTREOTIDE; PHENYLALANINE; RHENIUM 188; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; THIOL DERIVATIVE; TYROSINE;

ACETYLATION; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CYCLIZATION; DRUG SYNTHESIS; DRUG TARGETING; ELECTROSPRAY MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RECEPTOR BINDING; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CHELATING AGENTS; CYCLIZATION; DISULFIDES; MAGNETIC RESONANCE SPECTROSCOPY; OCTREOTIDE; RADIOLIGAND ASSAY; RATS; RECEPTORS, SOMATOSTATIN; RHENIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 41649111878     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701056x     Document Type: Article

References (27)

1. Van Essen, M.; Krenning Eric, P.; de long, M.; Valkema, R.; Kwekkeboom Dik, J. Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues in Patients with Somatostatin Receptor Positive Tumours. Acta Oncol. 2007, 46, 723-734.
2. 111In-Labeled Somatostatin Analogs for Tumor Scintigraphy and Radionuclide Therapy. Cancer Res. 1998, 58, 437-441.
3. 3] Octreotide, a Promising Somatostatin Analog for Radionuclide Therapy. Eur. J. Nucl. Med. 1997, 24, 368-371.
4. Heppeler, A.; Froidevaux, S.; Macke, H. R.; Jermann, E.; Behe, M.; Powell, P.; Hennig, M. Radiometal-Labelled Macrocyclic Chelator-Derivatized Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy. Chem. - Eur. J. 1999, 5, 1974-1981.
5. 177Lu-DOTA-Y3-Octreotate in a Rat Model. Int. J. Cancer 2001, 94, 873-877.
6. 0]Octreotide in Patients. Eur. J. Nucl. Med. 2001, 28, 1319-1325.
7. 64Cu-TETA-Octreotide as a PET Imaging Agent for Patients with Neuroendocrine Tumors. J. Nucl. Med. 2001, 42, 213-221.
8. 64Cu-Labeled Somatostatin Analogs in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy. J. Med. Chem. 1999, 42, 1341-1347.
9. 3-Octreotate. A New Somatostatin Analog with Improved Target Tissue Uptake. Nucl. Med. Biol. 1999, 26, 267-273.
10. 111In-Labelled Octreotide Derivatives. Eur. J. Nucl. Med. 2000, 27, 1318-1325.
11. 111In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors. J. Nucl. Med. 2003, 44, 708-716.
12. 99mTechnetium-Labeled Cyclic α-Melanocyte-Stimulating Hormone Peptide Analogues. Cancer Res. 2000, 60, 5649-5658.
13. Giblin, M. F.; Wang, N.; Hoffman, T. J.; Jurisson, S. S.; Quinn, T. P. Design and Characterization of α-Melanotropin Peptide Analogs Cyclized through Rhenium and Technetium Metal Coordination. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 12814-12818.
14. 111In-DOTA-Rhenium Cyclized Alpha-MSH Analog: A Novel Cyclic-Peptide Analog with Improved Tumor-Targeting Properties. J. Nucl. Med. 2001, 42, 1847-1855.
15. Cheng, Z.; Chen, J.; Quinn, T. P.; Jurisson, S. S. Radioiodination of Rhenium Cyclized α-Melanocyte-Stimulating Hormone Resulting in Enhanced Radioactivity Localization and Retention in Melanoma. Cancer Res. 2004, 64, 1411-1418.
16. 188Re-RC-160, a Directly-Radiolabeled Somatostatin Analog. Int. J. Cancer 1996, 65, 214-220.
17. 188Re-RC-160, a Somatostatin Analog. Tumor Targeting 1996, 2, 49-59.
18. Hosono, M.; Hosono, M. N.; Haberberger, T.; Zamora, P. O.; Guhlke, S.; Bender, H.; Knapp, F. F. R.; Biersack, H. J. Localization of Small-Cell Lung Cancer Xenografts with Iodine-125-, Indium-111-, and Rhenium-188-Somatostatin Analogs. Jpn. J. Cancer Res. 1996, 87, 995-1000.
19. 188Re-Somatostatin Analogues: Stannous-Mediated Direct-Labelling and Biodistribution in Normal Mice. In Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine; Nicolini, M., Mazzi, U., Eds.; SGE Editoriali: Padova, Italy. 1995; Vol. 4, 367-372.
20. Reubi, J. C.; Schar, J.-C.; Waser, B.; Wenger, S.; Heppeler, A.; Schmitt, J. S.; Macke, H. R. Affinity Profiles for Human Somatostatin Receptor Subtypes SST1-SST5 of Somatostatin Radiotracers Selected for Scintigraphic and Radiotherapeutic Use. Eur. J. Nucl. Med. 2000, 27, 273-282.
21. Bigott, H. M.; Dannoon, S. F.; Figueroa, S. D.; Hoffman, T. J.; Jurisson, S. S.; Lewis, M. R. Biodistribution and Imaging Studies of Somatostatin Receptors Using Technetium-99m-Cyclized Tyrosine-3-Octreotate. In Technetium, Rhenium and Other Metals in Chemistry and Nuclear Medicine, Mazzi, U., Ed.; SGE Editoriali: Padova, Italy, 2006; Vol. 7, pp 295-300.
22. Giblin, M. F.; Jurisson, S. S.; Quinn, T. P. Synthesis and Characterization of Rhenium-Complexed α-Melanotropin Analogs. Bioconjugate Chem. 1997, 8, 347-353.
23. Grove, D. E.; Wilkinson, G. Oxo-Complexes of Rhenium(V). J. Chem. Soc., A, Inorg. Phys. Theoret. 1966, 1224, 1230.
24. Delaglio, F.; Grzesiek, S.; Vuister, G. W.; Zhu, G.; Pfeifer, J.; Bax, A. NMRPipe: A Multidimensional Spectral Processing System Based on UNIX Pipes. J. Biomol. NMR 1995, 6, 277-293.
25. 15N Chemical Shift Referencing in Biomolecular NMR. J. Biomol. NMR 1995, 6, 135-140.
26. 177Lu at High Specific Activities. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 917-920.
27. 2: An in Vitro/in Vivo Structure-Activity Relationship Study Where X = 0-, 3-, 5-, 8-, and 11-Carbon Tethering Moieties. Bioconjugate Chem. 2003, 14, 93-102.